Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BORR
1851
Borr Drilling
BORR
$1.25B
| $2.97M | ﹤0.01% |
1,625,501
+1,222,341
| +303% | +$2.31M |
|
1852
Estee Lauder
EL
$31.6B
| $2.97M | ﹤0.01% |
+36,800
| New | +$2.37M |
|
1853
Silvercrest Asset Management
SAMG
$79.5M
| $2.97M | ﹤0.01% |
187,437
+29,700
| +19% | +$449K |
|
1854
Riley Exploration Permian
REPX
$786M
| $2.97M | ﹤0.01% |
113,200
+6,354
| +6% | +$168K |
|
|
XRN
1855
Chiron Real Estate Inc
XRN
$484M
| $2.96M | ﹤0.01% |
85,540
+900
| +1% | +$31.3K |
|
|
SCHV
1856
Schwab US Large-Cap Value ETF
SCHV
$16.3B
| $2.96M | ﹤0.01% |
107,100
+85,500
| +396% | +$2.25M |
|
1857
Alight
ALIT
$394M
| $2.96M | ﹤0.01% |
+26,160
| New | +$2.8M |
|
1858
Krispy Kreme
DNUT
$569M
| $2.96M | ﹤0.01% |
1,015,600
+981,107
| +2,844% | +$3.42M |
|
|
INR
1859
Infinity Natural Resources
INR
$256M
| $2.95M | ﹤0.01% |
161,300
+102,100
| +172% | +$1.74M |
|
1860
Chegg
CHGG
$89.3M
| $2.95M | ﹤0.01% |
2,437,300
+438,900
| +22% | +$406K |
|
1861
Smith & Nephew
SNN
$12.6B
| $2.95M | ﹤0.01% |
+96,250
| New | +$2.72M |
|
1862
Organogenesis Holdings
ORGO
$226M
| $2.94M | ﹤0.01% |
803,900
-239,600
| -23% | -$893K |
|
1863
OceanFirst Financial
OCFC
$1.88B
| $2.94M | ﹤0.01% |
167,052
+30,209
| +22% | +$504K |
|
1864
iShares Core S&P US Value ETF
IUSV
$28B
| $2.93M | ﹤0.01% |
+31,000
| New | +$2.8M |
|
1865
First Community Bankshares
FCBC
$933M
| $2.93M | ﹤0.01% |
74,833
+31,239
| +72% | +$1.19M |
|
1866
Brookfield
BN
$111B
| $2.93M | ﹤0.01% |
+71,045
| New | +$2.63M |
|
1867
Fortrea Holdings
FTRE
$1.69B
| $2.93M | ﹤0.01% |
592,600
+207,100
| +54% | +$1.11M |
|
1868
PAR Technology
PAR
$770M
| $2.93M | ﹤0.01% |
42,200
-128,900
| -75% | -$8.05M |
|
1869
Tucows
TCX
$134M
| $2.92M | ﹤0.01% |
148,351
-4,300
| -3% | -$77K |
|
1870
Steven Madden
SHOO
$3.46B
| $2.91M | ﹤0.01% |
121,467
-14,300
| -11% | -$336K |
|
1871
City Holding Co
CHCO
$2.08B
| $2.91M | ﹤0.01% |
23,788
+13,600
| +133% | +$1.6M |
|
1872
Arcos Dorados Holdings
ARCO
$1.71B
| $2.91M | ﹤0.01% |
368,434
+171,600
| +87% | +$1.3M |
|
|
ACB
1873
Aurora Cannabis
ACB
$235M
| $2.91M | ﹤0.01% |
685,555
+19,222
| +3% | +$93.2K |
|
1874
American Coastal Insurance
ACIC
$461M
| $2.91M | ﹤0.01% |
261,357
+10,400
| +4% | +$115K |
|
1875
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
| $2.9M | ﹤0.01% |
10,200
+7,900
| +343% | +$2.04M |
|
Similar funds
Jim Simons's Q2 2025 Portfolio in Review
As of Q2 2025, Jim Simons held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Jim Simons added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Jim Simons's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Jim Simons fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Jim Simons's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Jim Simons opened 612 new positions and closed 496 in Q2 2025.
- Jim Simons's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.